Developer docs
API playgroundTry for free, no card

Search company profiles

Svision

Full company profile

uuid0002jm5

Namestring
Svision
Legal namestring
Intalight
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Svision (operating internationally as Intalight) is a private medical device company founded in 2014 by Silicon Valley scientists and industry veterans to develop advanced ophthalmic imaging technology. The company moved its operational base to mainland China in 2015 and currently operates from three sites — San Jose, California; Shanghai; and Luoyang, Henan — with 51–100 employees. Its flagship product, the DREAM OCT™, is a Swept-Source Optical Coherence Tomography device that combines deep imaging depth, rapid sweeping speed, extensive scan range, accurate lesion detection, and multimodal imaging capabilities in a single platform.

The DREAM OCT platform, launched in 2019, has been adopted by leading ophthalmology institutions worldwide, including Bascom Palmer Eye Institute, Casey Eye Institute, Doheny Eye Institute, Institute of Science Tokyo, Neovista Eye Institute, and The Retina Clinic – London Ophthalmic Institute, and has been cited in over 170 peer-reviewed publications. The company sells hardware through a direct sales model organized by geography — APAC, EMEA, and the Americas — and generates recurring service revenue from installed devices. Regulatory milestones to date include Brazilian ANVISA approval (June 2024) and CE Mark certification (May 2025), while US FDA clearance remains pending.

Svision is privately held with cumulative disclosed funding of approximately $60M raised across rounds from 2018 through 2025. Capital sources include strategic investor Aier Eye Hospital Group (China's largest ophthalmology chain), China Life Private Equity, CICC, Shenzhen Capital Group, Haitong Capital, Co-Stone Venture Capital, Qianhai Fund of Funds, and others. The company states its product portfolio is extending from diagnostic imaging devices into operational (surgical) ophthalmic instruments, signaling a planned expansion of its addressable market beyond the current single-platform offering.

Short descriptiontext

Svision (Intalight) develops the DREAM OCT™ Swept-Source Optical Coherence Tomography imaging platform for ophthalmologists, hospitals, and research institutions, with operations across China, the US, Brazil, Japan, and the UK.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLuoyang, China
HQ citystring
Luoyang
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ophthalmic imaging devices, swept-source OCT, retinal imaging equipment, multimodal eye imaging, diagnostic ophthalmology
Industry1 code
PRIMARYHLAHAJAB
Retinal Imaging & OCT Systems (OCT/OCTA, Fundus Cameras, Fluorescein/ICG Angiography)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical and Medical Instrument Manufacturing339112
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Ophthalmic Diagnostic Imaging Equipment
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Device Sales
TypeOne Time License
Description

Sale of DREAM OCT™ Swept-Source OCT devices to ophthalmologists, hospitals, and research institutions for clinical and research use. The company generates revenue from hardware sales of diagnostic imaging equipment.

intalight.com
2Service and Support
TypeSubscription Recurring
Description

Technical support and service offerings for installed device base through regional support contacts (service.apac@intalight.com, service.emea@intalight.com, service.americas@intalight.com)

intalight.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1DREAM OCT™
Description

Swept-Source Optical Coherence Tomography (OCT) device with Deep imaging depth, Rapid sweeping speed, Extensive scan range, Accurate lesion detection, and Multimodal imaging capabilities.

intalight.com
Core offering1 text field

Svision (also operating as Intalight) designs, manufactures, and sells DREAM OCT™, a Swept-Source Optical Coherence Tomography (OCT) imaging device for ophthalmologists, hospitals, eye clinics, and academic research institutions. The device combines deep imaging depth, rapid sweeping speed, extensive scan range, accurate lesion detection, and multimodal imaging in a single unit, and is sold alongside regional service and technical support. The company is also extending its portfolio from diagnostic devices toward operational ophthalmic instruments.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 170+ peer-reviewed papers published using DREAM OCT devices
Product overview1 text field

The company offers a unified product portfolio centered on the DREAM OCT, a Swept-Source Optical Coherence Tomography device. The product portfolio is extending from ophthalmic diagnostic devices to operational instruments, aiming to empower ophthalmologists and benefit patients worldwide. The core product DREAM OCT combines five key imaging capabilities: Deep imaging depth, Rapid sweeping speed, Extensive scan range, Accurate lesion detection, and Multimodal imaging.

Product and service1 record
1DREAM OCT™ Swept-Source OCT Imaging Device
CategoryOphthalmic Diagnostic Imaging Equipment
Description

Capital ophthalmic imaging hardware device that performs swept-source optical coherence tomography for ophthalmologists, hospitals, eye clinics, and academic research institutions. Provides deep imaging depth, rapid sweeping speed, extensive scan range, accurate lesion detection, and multimodal imaging in a single unit, used for clinical diagnosis of retinal disease and for ophthalmic research.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Market position
Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors13 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Svision

Ophthalmic Diagnostic Imaging Equipmentsvisionimaging.com

Svision (Intalight) develops the DREAM OCT™ Swept-Source Optical Coherence Tomography imaging platform for ophthalmologists, hospitals, and research institutions, with operations across China, the US, Brazil, Japan, and the UK.

What Svision does

Svision (operating internationally as Intalight) is a private medical device company founded in 2014 by Silicon Valley scientists and industry veterans to develop advanced ophthalmic imaging technology. The company moved its operational base to mainland China in 2015 and currently operates from three sites — San Jose, California; Shanghai; and Luoyang, Henan — with 51–100 employees. Its flagship product, the DREAM OCT™, is a Swept-Source Optical Coherence Tomography device that combines deep imaging depth, rapid sweeping speed, extensive scan range, accurate lesion detection, and multimodal imaging capabilities in a single platform.

The DREAM OCT platform, launched in 2019, has been adopted by leading ophthalmology institutions worldwide, including Bascom Palmer Eye Institute, Casey Eye Institute, Doheny Eye Institute, Institute of Science Tokyo, Neovista Eye Institute, and The Retina Clinic – London Ophthalmic Institute, and has been cited in over 170 peer-reviewed publications. The company sells hardware through a direct sales model organized by geography — APAC, EMEA, and the Americas — and generates recurring service revenue from installed devices. Regulatory milestones to date include Brazilian ANVISA approval (June 2024) and CE Mark certification (May 2025), while US FDA clearance remains pending.

Svision is privately held with cumulative disclosed funding of approximately $60M raised across rounds from 2018 through 2025. Capital sources include strategic investor Aier Eye Hospital Group (China's largest ophthalmology chain), China Life Private Equity, CICC, Shenzhen Capital Group, Haitong Capital, Co-Stone Venture Capital, Qianhai Fund of Funds, and others. The company states its product portfolio is extending from diagnostic imaging devices into operational (surgical) ophthalmic instruments, signaling a planned expansion of its addressable market beyond the current single-platform offering.

Svision firmographics

Firmographics
Name
Svision
Legal name
Intalight
Website
https://svisionimaging.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
1–10 employees
Short description
Svision (Intalight) develops the DREAM OCT™ Swept-Source Optical Coherence Tomography imaging platform for ophthalmologists, hospitals, and research institutions, with operations across China, the US, Brazil, Japan, and the UK.
Ownership category
akta.pro rank

Svision industry classification

Industry
Product category
Ophthalmic Diagnostic Imaging Equipment
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAJAB
Retinal Imaging & OCT Systems (OCT/OCTA, Fundus Cameras, Fluorescein/ICG Angiography)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)

Keywords

  • Ophthalmic imaging devices
  • Swept-source OCT
  • Retinal imaging equipment
  • Multimodal eye imaging
  • Diagnostic ophthalmology

Where Svision is headquartered

Location

Headquarters

HQ city
Luoyang
HQ country
China
HQ region
Asia

Offices3 records

Markets served

Svision business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Revenue model

  1. Medical Device Sales: Sale of DREAM OCT™ Swept-Source OCT devices to ophthalmologists, hospitals, and research institutions for clinical and research use. The company generates revenue from hardware sales of diagnostic imaging equipment.
  2. Service and Support: Technical support and service offerings for installed device base through regional support contacts (service.apac@intalight.com, service.emea@intalight.com, service.americas@intalight.com)

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Svision product offering

Product offering

Core offering

Svision (also operating as Intalight) designs, manufactures, and sells DREAM OCT™, a Swept-Source Optical Coherence Tomography (OCT) imaging device for ophthalmologists, hospitals, eye clinics, and academic research institutions. The device combines deep imaging depth, rapid sweeping speed, extensive scan range, accurate lesion detection, and multimodal imaging in a single unit, and is sold alongside regional service and technical support. The company is also extending its portfolio from diagnostic devices toward operational ophthalmic instruments.

Product overview

The company offers a unified product portfolio centered on the DREAM OCT, a Swept-Source Optical Coherence Tomography device. The product portfolio is extending from ophthalmic diagnostic devices to operational instruments, aiming to empower ophthalmologists and benefit patients worldwide. The core product DREAM OCT combines five key imaging capabilities: Deep imaging depth, Rapid sweeping speed, Extensive scan range, Accurate lesion detection, and Multimodal imaging.

Differentiator

Problem solved

Functional benefit

Brands

  • DREAM OCT™: Swept-Source Optical Coherence Tomography (OCT) device with Deep imaging depth, Rapid sweeping speed, Extensive scan range, Accurate lesion detection, and Multimodal imaging capabilities.

Products and services

  • DREAM OCT™ Swept-Source OCT Imaging Device Capital ophthalmic imaging hardware device that performs swept-source optical coherence tomography for ophthalmologists, hospitals, eye clinics, and academic research institutions. Provides deep imaging depth, rapid sweeping speed, extensive scan range, accurate lesion detection, and multimodal imaging in a single unit, used for clinical diagnosis of retinal disease and for ophthalmic research.

Quantifiable outcome

  • 170+ peer-reviewed papers published using DREAM OCT devices

Companies that use Svision

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles2 records

Svision technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Svision partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves8 records

Expansion highlights7 records

Svision competitors and assessment

Company assessment

Market position

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Svision compliance and trust

Trust signal

Compliance1 record

Svision financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Svision leadership team

Management profile

Number of profiles

Profiles1 record

Svision funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors13 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Svision M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Svision

What does Svision do?

Svision (also operating as Intalight) designs, manufactures, and sells DREAM OCT™, a Swept-Source Optical Coherence Tomography (OCT) imaging device for ophthalmologists, hospitals, eye clinics, and academic research institutions. The device combines deep imaging depth, rapid sweeping speed, extensive scan range, accurate lesion detection, and multimodal imaging in a single unit, and is sold alongside regional service and technical support. The company is also extending its portfolio from diagnostic devices toward operational ophthalmic instruments.

Is Svision a public or private company?

Svision is a private company. It is classified as venture growth investor backed and is currently operating.

When was Svision founded?

Svision was founded in 2014. It employs 1 to 10 people.

Where is Svision based?

Svision is headquartered in Luoyang, China, in the Asia region.

How does Svision make money?

Two revenue lines are on record. Medical Device Sales are the primary driver. The others are service and Support.

Does Svision have an API?

No public API is recorded for Svision.

What industry is Svision in?

Svision's product category is Ophthalmic Diagnostic Imaging Equipment. Its primary akta.pro industry code is HLAHAJAB, Retinal Imaging & OCT Systems (OCT/OCTA, Fundus Cameras, Fluorescein/ICG Angiography). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales